facundo fiocca vernengo
Institute of Microbiology, Infectious Diseases and Immunology, Charité Medical University of Berlin
Berlin, Germany
Review Editor
Cancer Immunity and Immunotherapy
Institute of Microbiology, Infectious Diseases and Immunology, Charité Medical University of Berlin
Berlin, Germany
Review Editor
Cancer Immunity and Immunotherapy
Lyell Immunopharma, Inc.
Seattle, United States
Review Editor
Cancer Immunity and Immunotherapy
Pontifical Javeriana University
Bogotá, Colombia
Review Editor
Cancer Immunity and Immunotherapy
National Cancer Institute
Bethesda, United States
Review Editor
Cancer Immunity and Immunotherapy
Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne, Switzerland
Review Editor
Cancer Immunity and Immunotherapy
Department of Medical BioSciences, Radboud University Medical Center
Nijmegen, Netherlands
Review Editor
Cancer Immunity and Immunotherapy
Rutgers, The State University of New Jersey
New Brunswick, United States
Review Editor
Cancer Immunity and Immunotherapy
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Immunity and Immunotherapy
Baylor College of Medicine
Houston, United States
Review Editor
Cancer Immunity and Immunotherapy
INSERM
La Tronche, France
Review Editor
Cancer Immunity and Immunotherapy
GSI Helmholtz Center for Heavy Ion Research, Helmholtz Association of German Research Centres (HZ)
Darmstadt, Germany
Review Editor
Cancer Immunity and Immunotherapy
IRCCS Ca 'Granda Foundation Maggiore Policlinico Hospital
Milan, Italy
Review Editor
Cancer Immunity and Immunotherapy
Poseida Therapeutic
San Diego, United States
Review Editor
Cancer Immunity and Immunotherapy
Academic Medical Center
Amsterdam, Netherlands
Review Editor
Cancer Immunity and Immunotherapy
International Clinical Research Center (FNUSA-ICRC)
Brno, Czechia
Review Editor
Cancer Immunity and Immunotherapy
Tel Aviv University
Tel Aviv, Israel
Review Editor
Cancer Immunity and Immunotherapy